10 20 30 40 50 60 70 80 2NQI - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 31-OCT-06 2NQI
TITLE CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY WR13(R,R), AN TITLE 2 EPOXYSUCCINYL-TYPE INHIBITOR.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALPAIN-1 CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CALPAIN CATALYTIC DOMAIN, RESIDUES 27-356; COMPND 5 SYNONYM: CALPAIN-1 LARGE SUBUNIT, CALCIUM-ACTIVATED COMPND 6 NEUTRAL PROTEINASE 1, CANP 1, CALPAIN MU-TYPE, MUCANP, COMPND 7 MICROMOLAR-CALPAIN; COMPND 8 EC: 3.4.22.52; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: CAPN1, CLS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24D
KEYWDS EPOXIDE, EPOXYSUCCINYL, PROTEASE, PEPTIDASE, PROTEINASE, KEYWDS 2 INACTIVATOR, INHIBITOR, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR D.CUERRIER,P.L.DAVIES,R.L.CAMPBELL,T.MOLDOVEANU
REVDAT 3 24-FEB-09 2NQI 1 VERSN REVDAT 2 10-APR-07 2NQI 1 JRNL REVDAT 1 09-JAN-07 2NQI 0
JRNL AUTH D.CUERRIER,T.MOLDOVEANU,R.L.CAMPBELL,J.KELLY, JRNL AUTH 2 B.YORUK,S.H.L.VERHELST,D.GREENBAUM,M.BOGYO, JRNL AUTH 3 P.L.DAVIES JRNL TITL DEVELOPMENT OF CALPAIN-SPECIFIC INACTIVATORS BY JRNL TITL 2 SCREENING OF POSITIONAL SCANNING EPOXIDE LIBRARIES JRNL REF J.BIOL.CHEM. V. 282 9600 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17218315 JRNL DOI 10.1074/JBC.M610372200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.04 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 15556 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1057 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.04 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1300 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.1890 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 153 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : 0.07000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.220 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.443 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.885 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2746 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3725 ; 1.659 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 321 ; 6.689 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 138 ;37.553 ;24.348 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 459 ;14.988 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;20.481 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 398 ; 0.121 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2113 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1352 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1858 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 174 ; 0.181 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 9 ; 0.081 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 69 ; 0.283 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.281 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1661 ; 1.088 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2603 ; 1.762 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1286 ; 2.530 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1122 ; 3.684 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 2NQI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-06. REMARK 100 THE RCSB ID CODE IS RCSB040179.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL MIRRORS REMARK 200 OPTICS : OSMIC CONFOCAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19556 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.040 REMARK 200 RESOLUTION RANGE LOW (A) : 59.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2G8J REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: EXPANSION AROUND 1.1-1.7 M NACL, 10 REMARK 280 MM CACL2, AND 0.1 M MES (PH 6.0), VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.18450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.37150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.03000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.37150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.18450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.03000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 26 REMARK 465 GLY A 27 REMARK 465 LEU A 28 REMARK 465 GLY A 29 REMARK 465 ARG A 30 REMARK 465 HIS A 31 REMARK 465 GLU A 32 REMARK 465 PRO A 355 REMARK 465 ASP A 356 REMARK 465 LEU A 357 REMARK 465 GLU A 358 REMARK 465 HIS A 359 REMARK 465 HIS A 360 REMARK 465 HIS A 361 REMARK 465 HIS A 362 REMARK 465 HIS A 363 REMARK 465 HIS A 364
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 545 O HOH A 653 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 51 NH1 ARG A 339 2555 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 61 70.03 -151.75 REMARK 500 LYS A 71 -87.82 -126.94 REMARK 500 GLN A 142 -125.19 -110.70 REMARK 500 PHE A 177 -136.69 -98.88 REMARK 500 LYS A 229 37.93 -143.25 REMARK 500 ILE A 257 -43.64 163.97 REMARK 500 ARG A 258 23.20 177.45 REMARK 500 ASP A 259 49.37 -88.00 REMARK 500 LEU A 260 25.10 -157.72 REMARK 500 GLU A 261 159.03 83.29 REMARK 500 VAL A 301 91.48 78.19 REMARK 500 TRP A 303 132.28 -33.90 REMARK 500 TRP A 307 -4.96 89.07 REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 401 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 182 OE1 REMARK 620 2 ASP A 106 OD1 76.5 REMARK 620 3 GLY A 101 O 145.5 125.5 REMARK 620 4 ASP A 106 OD2 127.1 50.9 81.3 REMARK 620 5 HOH A 544 O 75.8 85.2 79.9 101.4 REMARK 620 6 GLU A 185 OE1 77.9 68.6 132.3 78.5 146.4 REMARK 620 7 GLU A 185 OE2 111.4 109.6 87.4 85.3 164.6 48.3 REMARK 620 8 VAL A 99 O 77.1 153.6 78.1 155.4 88.2 105.8 80.4 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 402 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 329 O REMARK 620 2 GLU A 333 O 160.7 REMARK 620 3 HOH A 536 O 96.2 87.4 REMARK 620 4 GLU A 302 OE1 107.0 76.5 151.2 REMARK 620 5 GLU A 302 OE2 76.4 91.9 153.2 52.8 REMARK 620 6 ASP A 331 OD1 78.3 83.7 79.9 120.9 73.4 REMARK 620 7 ASP A 309 OD2 114.0 85.3 77.6 77.4 129.0 155.4 REMARK 620 8 ASP A 309 OD1 71.7 127.5 87.2 84.0 113.8 145.8 42.7 REMARK 620 N 1 2 3 4 5 6 7
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 401 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 402 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NQI A 501
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2NQG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, INACTIVATED REMARK 900 BY WR18(S,S), ANOTHER EPOXYSUCCINYL INHIBITOR WITH OPPOSITE REMARK 900 STEREOCHEMISTRY. REMARK 900 RELATED ID: 1TLO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, INACTIVATED REMARK 900 BY E-64, ANOTHER EPOXYSUCCINYL INHIBITOR. REMARK 900 RELATED ID: 1KXR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, UNCOMPLEXED. REMARK 900 RELATED ID: 1TL9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED REMARK 900 WITH LEUPEPTIN, AN ALDEHYDE INHIBITOR. REMARK 900 RELATED ID: 2G8J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED REMARK 900 WITH SNJ-1945, AN ALPHA-KETOAMIDE INHIBITOR. REMARK 900 RELATED ID: 2G8E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED REMARK 900 WITH SNJ-1715, A CYCLIC HEMIACETAL INHIBITOR.
DBREF 2NQI A 27 356 UNP P97571 CAN1_RAT 27 356
SEQADV 2NQI MET A 26 UNP P97571 INITIATING METHIONINE SEQADV 2NQI LEU A 357 UNP P97571 CLONING ARTIFACT SEQADV 2NQI GLU A 358 UNP P97571 CLONING ARTIFACT SEQADV 2NQI HIS A 359 UNP P97571 EXPRESSION TAG SEQADV 2NQI HIS A 360 UNP P97571 EXPRESSION TAG SEQADV 2NQI HIS A 361 UNP P97571 EXPRESSION TAG SEQADV 2NQI HIS A 362 UNP P97571 EXPRESSION TAG SEQADV 2NQI HIS A 363 UNP P97571 EXPRESSION TAG SEQADV 2NQI HIS A 364 UNP P97571 EXPRESSION TAG
SEQRES 1 A 339 MET GLY LEU GLY ARG HIS GLU ASN ALA ILE LYS TYR LEU SEQRES 2 A 339 GLY GLN ASP TYR GLU ASN LEU ARG ALA ARG CYS LEU GLN SEQRES 3 A 339 ASN GLY VAL LEU PHE GLN ASP ASP ALA PHE PRO PRO VAL SEQRES 4 A 339 SER HIS SER LEU GLY PHE LYS GLU LEU GLY PRO ASN SER SEQRES 5 A 339 SER LYS THR TYR GLY ILE LYS TRP LYS ARG PRO THR GLU SEQRES 6 A 339 LEU LEU SER ASN PRO GLN PHE ILE VAL ASP GLY ALA THR SEQRES 7 A 339 ARG THR ASP ILE CYS GLN GLY ALA LEU GLY ASP CYS TRP SEQRES 8 A 339 LEU LEU ALA ALA ILE ALA SER LEU THR LEU ASN GLU THR SEQRES 9 A 339 ILE LEU HIS ARG VAL VAL PRO TYR GLY GLN SER PHE GLN SEQRES 10 A 339 GLU GLY TYR ALA GLY ILE PHE HIS PHE GLN LEU TRP GLN SEQRES 11 A 339 PHE GLY GLU TRP VAL ASP VAL VAL VAL ASP ASP LEU LEU SEQRES 12 A 339 PRO THR LYS ASP GLY LYS LEU VAL PHE VAL HIS SER ALA SEQRES 13 A 339 GLN GLY ASN GLU PHE TRP SER ALA LEU LEU GLU LYS ALA SEQRES 14 A 339 TYR ALA LYS VAL ASN GLY SER TYR GLU ALA LEU SER GLY SEQRES 15 A 339 GLY CYS THR SER GLU ALA PHE GLU ASP PHE THR GLY GLY SEQRES 16 A 339 VAL THR GLU TRP TYR ASP LEU GLN LYS ALA PRO SER ASP SEQRES 17 A 339 LEU TYR GLN ILE ILE LEU LYS ALA LEU GLU ARG GLY SER SEQRES 18 A 339 LEU LEU GLY CYS SER ILE ASN ILE SER ASP ILE ARG ASP SEQRES 19 A 339 LEU GLU ALA ILE THR PHE LYS ASN LEU VAL ARG GLY HIS SEQRES 20 A 339 ALA TYR SER VAL THR ASP ALA LYS GLN VAL THR TYR GLN SEQRES 21 A 339 GLY GLN ARG VAL ASN LEU ILE ARG MET ARG ASN PRO TRP SEQRES 22 A 339 GLY GLU VAL GLU TRP LYS GLY PRO TRP SER ASP ASN SER SEQRES 23 A 339 TYR GLU TRP ASN LYS VAL ASP PRO TYR GLU ARG GLU GLN SEQRES 24 A 339 LEU ARG VAL LYS MET GLU ASP GLY GLU PHE TRP MET SER SEQRES 25 A 339 PHE ARG ASP PHE ILE ARG GLU PHE THR LYS LEU GLU ILE SEQRES 26 A 339 CYS ASN LEU THR PRO ASP LEU GLU HIS HIS HIS HIS HIS SEQRES 27 A 339 HIS
HET CA A 401 1 HET CA A 402 1 HET NQI A 501 43
HETNAM CA CALCIUM ION HETNAM NQI N~2~-[(2S)-2-{[(2R)-4-ETHOXY-2-HYDROXY-4- HETNAM 2 NQI OXOBUTANOYL]AMINO}PENT-4-ENOYL]-L-ARGINYL-L- HETNAM 3 NQI TRYPTOPHANAMIDE
FORMUL 2 CA 2(CA 2+) FORMUL 4 NQI C28 H40 N8 O7 FORMUL 5 HOH *153(H2 O)
HELIX 1 1 LEU A 38 GLN A 40 5 3 HELIX 2 2 ASP A 41 GLY A 53 1 13 HELIX 3 3 VAL A 64 GLY A 69 1 6 HELIX 4 4 SER A 77 GLY A 82 1 6 HELIX 5 5 ARG A 87 LEU A 92 1 6 HELIX 6 6 THR A 103 ILE A 107 5 5 HELIX 7 7 ASP A 114 THR A 125 1 12 HELIX 8 8 ASN A 127 VAL A 135 1 9 HELIX 9 9 PHE A 186 ASN A 199 1 14 HELIX 10 10 TYR A 202 SER A 206 5 5 HELIX 11 11 CYS A 209 GLY A 219 1 11 HELIX 12 12 GLN A 228 ALA A 230 5 3 HELIX 13 13 ASP A 233 ARG A 244 1 12 HELIX 14 14 SER A 311 VAL A 317 5 7 HELIX 15 15 ASP A 318 ARG A 326 1 9 HELIX 16 16 PHE A 338 PHE A 345 1 8
SHEET 1 A 3 ILE A 35 LYS A 36 0 SHEET 2 A 3 GLU A 158 ASP A 165 1 O ASP A 161 N ILE A 35 SHEET 3 A 3 ILE A 148 GLN A 155 -1 N LEU A 153 O VAL A 160 SHEET 1 B 3 LYS A 84 LYS A 86 0 SHEET 2 B 3 LEU A 168 LYS A 171 -1 O THR A 170 N LYS A 84 SHEET 3 B 3 LYS A 174 LEU A 175 -1 O LYS A 174 N LYS A 171 SHEET 1 C 6 VAL A 221 ASP A 226 0 SHEET 2 C 6 LYS A 347 ASN A 352 -1 O LEU A 348 N TYR A 225 SHEET 3 C 6 LEU A 247 SER A 251 -1 N LEU A 247 O CYS A 351 SHEET 4 C 6 TYR A 274 TYR A 284 -1 O TYR A 274 N CYS A 250 SHEET 5 C 6 GLN A 287 ARG A 295 -1 O GLN A 287 N TYR A 284 SHEET 6 C 6 GLU A 333 SER A 337 -1 O MET A 336 N ILE A 292
LINK SG CYS A 115 CBS NQI A 501 1555 1555 1.79 LINK CA CA A 401 OE1 GLN A 182 1555 1555 2.34 LINK CA CA A 401 OD1 ASP A 106 1555 1555 2.66 LINK CA CA A 401 O GLY A 101 1555 1555 2.37 LINK CA CA A 401 OD2 ASP A 106 1555 1555 2.39 LINK CA CA A 401 O HOH A 544 1555 1555 2.48 LINK CA CA A 401 OE1 GLU A 185 1555 1555 2.74 LINK CA CA A 401 OE2 GLU A 185 1555 1555 2.57 LINK CA CA A 401 O VAL A 99 1555 1555 2.39 LINK CA CA A 402 O MET A 329 1555 1555 2.40 LINK CA CA A 402 O GLU A 333 1555 1555 2.28 LINK CA CA A 402 O HOH A 536 1555 1555 2.31 LINK CA CA A 402 OE1 GLU A 302 1555 1555 2.35 LINK CA CA A 402 OE2 GLU A 302 1555 1555 2.54 LINK CA CA A 402 OD1 ASP A 331 1555 1555 2.32 LINK CA CA A 402 OD2 ASP A 309 1555 1555 3.29 LINK CA CA A 402 OD1 ASP A 309 1555 1555 2.43
SITE 1 AC1 6 VAL A 99 GLY A 101 ASP A 106 GLN A 182 SITE 2 AC1 6 GLU A 185 HOH A 544 SITE 1 AC2 6 GLU A 302 ASP A 309 MET A 329 ASP A 331 SITE 2 AC2 6 GLU A 333 HOH A 536 SITE 1 AC3 18 GLN A 109 GLY A 113 ASP A 114 CYS A 115 SITE 2 AC3 18 TRP A 116 SER A 206 GLY A 207 GLY A 208 SITE 3 AC3 18 SER A 251 GLY A 271 HIS A 272 ALA A 273 SITE 4 AC3 18 GLN A 287 TRP A 298 ARG A 339 HOH A 552 SITE 5 AC3 18 HOH A 563 HOH A 636
CRYST1 40.369 70.060 110.743 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.024772 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014274 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009030 0.00000